Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Although UM and cutaneous melanoma are derived from melanocytes, UM differs clinically and biologically from its more common skin counterparts. More than half of primary UMs metastasize. However, there is currently no effective treatment for metastatic UM. Therefore, studying mutations related to the metastasis, growth, proliferation, and survival of UM can help researchers understand its pathogenesis and metastatic mechanism, thereby leading to a more effective treatment. In addition, we provide an overview of the recent basic and clinical studies to provide a strong foundation for developing novel anti-carcinogenesis targets for future interventions.
CITATION STYLE
Wu, M. Y., Lai, T. T., Liao, W. T., & Li, C. J. (2020). Clinicopathological and prognostic significance and molecular mechanisms governing uveal melanoma. Therapeutic Advances in Medical Oncology. SAGE Publications Inc. https://doi.org/10.1177/1758835920917566
Mendeley helps you to discover research relevant for your work.